Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial to Evaluate the Effects of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI

NCT03632213 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.

NCT NCT03632213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03632213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial to Evaluate the Effects of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI
Lead sponsor
Hospital de Clinicas de Porto Alegre
Phase
Phase 2
Overall status
Unknown status
Start date
November 7, 2018
Completion date
August 3, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

morquio a syndrome, morquio syndrome, morquio syndrome a, mps - mucopolysaccharidosis, mps iv a, mps vi, mucopolysaccharidoses, mucopolysaccharidosis iv a, mucopolysaccharidosis vi